| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 12 | -1.19M | 100% | $59.48 | -$70.5M |
| Net | -12 | -1.19M | -100% | -$70.5M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Meridian Venture Partners II Lp | More than 10% owner | $103M | -$11.7M | -10.2% | Aug 16, 2023 |
| Muthusamy Shanmugam | HEAD OF R&D, COO-NOVITIUM OPS, Director | $49.8M | -$35.2M | -41.4% | May 20, 2024 |
| Nikhil Lalwani | PRESIDENT & CEO, Director | $30.2M | -$8.08M | -21.1% | May 14, 2024 |
| Chad Gassert | Svp Corp. Dev. & Strategy | $18.8M | -$9.53M | -33.6% | May 1, 2024 |
| Stephen P. Carey | Svp & Cfo | $11.2M | -$1.59M | -12.5% | Apr 10, 2024 |
| James G. Marken | Svp Ops & Prod Dev | $7.77M | -$1.86M | -19.3% | Apr 10, 2024 |
| Ori Gutwerg | Svp, Generics | $5.78M | -$971K | -14.4% | Mar 7, 2024 |
| Christopher Mutz | Head Of Rare Disease | $5.13M | -$611K | -10.6% | May 21, 2024 |
| Patrick D. Walsh | Director | $4.6M | May 21, 2024 | ||
| Meredith Cook | Sr. Vp, General Counsel & Sec. | $4.03M | -$104K | -2.52% | May 13, 2024 |
| Krista Davis | Svp, Chief Hr Officer | $3.49M | -$141K | -3.89% | Feb 29, 2024 |
| Thomas Haughey | Director | $3.17M | May 21, 2024 | ||
| Robert E. Brown JR | Director | $2.77M | Apr 27, 2022 | ||
| Jeanne Thoma | Director | $2.5M | May 21, 2024 | ||
| Thomas Rowland | Svp, Head Established Brands | $2.29M | Mar 28, 2024 | ||
| David Nash | Director | $2.18M | May 23, 2023 | ||
| Antonio R. Pera | Director | $1.91M | -$638K | -25% | May 21, 2024 |
| Renee P. Tannenbaum | Director | $1.39M | -$128K | -8.4% | May 21, 2024 |
| Matthew J. Leonard | Director | $739K | May 21, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|